TrialSignal transduction and targeted therapy2025

Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial.

Dan-Yun Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.